| Financial Year |
March 31 2023 |
| Monetary Funds |
581,149,215.24 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
379,651,611.39 |
| Advances to Suppliers |
22,311,064.40 |
| Other Receivables |
25,706,281.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
645,070,291.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
69,079,826.10 |
| Total Current Assets |
1,796,288,252.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
86,601,634.67 |
| Investment Properties |
-- |
| Fixed Assetes |
1,658,480,338.91 |
| Under-construction Projects |
581,033,605.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
372,327,016.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,138,406.04 |
| Deferred Income Tax Assets |
62,704,614.48 |
| Other Non-Current Assets |
104,502,064.92 |
| Sub-Total of Non-Current Assets |
2,924,374,522.18 |
| Total Assets |
4,720,662,774.90 |
| Short-Term Loans |
649,372,453.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
407,406,568.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
77,281,792.65 |
| Taxes Payable |
46,385,422.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
107,983,814.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,321,708.03 |
| Other Current Liabilities |
2,815,534.36 |
| Sub-Total of Current Liabilities |
1,373,796,190.60 |
| Long-term Loans |
199,218,869.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
67,976,508.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
346,137,472.11 |
| Total Liabilities |
1,719,933,662.71 |
| Paid-In Capital(Or Share Stock) |
1,037,205,556.00 |
| Capital Surplus |
591,832,878.72 |
| Surplus Reserve |
412,382,145.31 |
| LESS:Treasury Stock |
99,942,900.00 |
| Undistributed Profits |
1,017,924,899.35 |
| Minority Stockholder's Interest |
36,247,466.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,964,481,645.97 |
| Owner's Equity（Stockholder's Equity） |
3,000,729,112.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,720,662,774.90 |
